Rhenman & Partners Asset Management AB

Latest statistics and disclosures from Rhenman & Partners Asset Management AB's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Rhenman & Partners Asset Management AB

Companies in the Rhenman & Partners Asset Management AB portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abbvie (ABBV) 4.4 $54M +78% 500k 107.15
BioMarin Pharmaceutical (BMRN) 3.6 $45M -31% 510k 87.69
Horizon Therapeutics Pub SHS (HZNP) 3.6 $44M -13% 600k 73.15
Medtronic SHS (MDT) 3.1 $38M +44% 320k 117.14
UnitedHealth (UNH) 3.0 $37M -4% 105k 350.68
Jazz Pharmaceuticals Shs Usd (JAZZ) 3.0 $36M +29% 220k 165.05
Eli Lilly & Co. (LLY) 2.5 $30M +9% 180k 168.84
Cigna Corp (CI) 2.4 $29M -6% 140k 208.18
CVS Caremark Corporation (CVS) 2.3 $29M +75% 420k 68.30
Merck & Co (MRK) 2.3 $28M +115% 344k 81.80
Vertex Pharmaceuticals Incorporated (VRTX) 2.2 $27M +4% 115k 236.34
Anthem (ANTM) 2.1 $26M -11% 80k 321.09
Humana (HUM) 1.9 $24M -3% 58k 410.28
Teladoc (TDOC) 1.9 $23M NEW 115k 199.96
Axonics Modulation Technolog (AXNX) 1.9 $23M 460k 49.92
Nektar Therapeutics (NKTR) 1.9 $23M +35% 1.4M 17.00
Gilead Sciences (GILD) 1.8 $22M +32% 385k 58.26
Mirati Therapeutics (MRTX) 1.8 $22M -12% 100k 219.64
Guardant Health (GH) 1.8 $22M -29% 170k 128.88
Bristol Myers Squibb (BMY) 1.7 $21M +17% 340k 62.03
Novocure Ord Shs (NVCR) 1.7 $21M -70% 120k 173.04
Acceleron Pharma (XLRN) 1.7 $21M +10% 160k 127.94
Abiomed (ABMD) 1.7 $20M -10% 63k 324.21
Biohaven Pharmaceutical Holding (BHVN) 1.6 $20M -24% 235k 85.71
Cooper Cos Com New (COO) 1.6 $20M -8% 55k 363.33
Regeneron Pharmaceuticals (REGN) 1.6 $19M +77% 40k 483.10
Boston Scientific Corporation (BSX) 1.6 $19M +17% 530k 35.95
Alexion Pharmaceuticals (ALXN) 1.5 $19M -45% 120k 156.24
Johnson & Johnson (JNJ) 1.5 $18M NEW 115k 157.38
Centene Corporation (CNC) 1.4 $17M -5% 285k 60.03
Baxter International (BAX) 1.3 $16M +32% 205k 80.24
Abbott Laboratories (ABT) 1.3 $16M -26% 150k 109.49
Intra Cellular Therapies (ITCI) 1.3 $16M +5% 500k 31.80
Apellis Pharmaceuticals (APLS) 1.3 $15M +20% 270k 57.20
Esperion Therapeutics (ESPR) 1.3 $15M +30% 592k 26.00
Iovance Biotherapeutics (IOVA) 1.2 $15M -5% 320k 46.40
Alnylam Pharmaceuticals (ALNY) 1.2 $15M +11% 112k 129.97
Neurocrine Biosciences (NBIX) 1.2 $14M +100% 150k 95.85
Macrogenics (MGNX) 1.2 $14M 625k 22.86
Sangamo Biosciences (SGMO) 1.0 $13M +21% 822k 15.61
Thermo Fisher Scientific (TMO) 1.0 $13M -8% 28k 465.79
Livanova SHS (LIVN) 1.0 $13M -9% 190k 66.21
Royalty Pharma Shs Class A (RPRX) 1.0 $13M NEW 250k 50.05
Hca Holdings (HCA) 1.0 $12M 75k 164.47
Aerie Pharmaceuticals (AERI) 0.9 $12M 850k 13.51
Edwards Lifesciences (EW) 0.9 $11M +4% 125k 91.23
Seagen (SGEN) 0.9 $11M NEW 65k 175.14
Xencor (XNCR) 0.9 $11M 259k 43.63
Becton, Dickinson and (BDX) 0.9 $11M +28% 45k 250.22
Zimmer Holdings (ZBH) 0.8 $10M -20% 65k 154.09
EXACT Sciences Corporation (EXAS) 0.8 $9.9M -6% 75k 132.49
Biogen Idec (BIIB) 0.8 $9.8M +21% 40k 244.85
Glaukos (GKOS) 0.8 $9.4M -10% 125k 75.26
Radius Health Com New (RDUS) 0.7 $8.6M +45% 482k 17.86
Silk Road Medical Inc Common (SILK) 0.6 $7.9M -10% 125k 62.98
Meiragtx Holdings (MGTX) 0.6 $6.8M +20% 450k 15.14
Adverum Biotechnologies (ADVM) 0.6 $6.8M 625k 10.84
Accolade (ACCD) 0.5 $6.5M 150k 43.50
Revance Therapeutics (RVNC) 0.5 $6.2M 220k 28.34
Shockwave Med (SWAV) 0.5 $6.2M 60k 103.72
Rigel Pharmaceuticals Com New (RIGL) 0.5 $6.1M 1.7M 3.50
Phathom Pharmaceuticals (PHAT) 0.5 $5.8M NEW 175k 33.22
Intuitive Surgical Com New (ISRG) 0.5 $5.7M -41% 7.0k 818.14
Agios Pharmaceuticals (AGIO) 0.5 $5.6M +44% 130k 43.33
Myovant Sciences (MYOV) 0.5 $5.5M -47% 200k 27.62
Fibrogen (FGEN) 0.4 $5.4M 145k 37.09
Arena Pharmaceuticals Com New (ARNA) 0.4 $5.4M -66% 70k 76.83
G1 Therapeutics (GTHX) 0.4 $4.3M +26% 240k 17.99
Five Prime Therapeutics (FPRX) 0.3 $4.3M NEW 250k 17.01
Alkermes SHS (ALKS) 0.3 $4.2M -32% 209k 19.95
Dynavax Technologies Corp Com New (DVAX) 0.3 $4.1M 926k 4.45
Oak Street Health (OSH) 0.3 $3.7M NEW 60k 61.17
Deciphera Pharmaceuticals (DCPH) 0.3 $3.4M NEW 60k 57.07
Annexon (ANNX) 0.3 $3.3M NEW 130k 25.03
Viewray (VRAY) 0.2 $3.0M 775k 3.82
Epizyme (EPZM) 0.2 $2.9M 265k 10.86
Stereotaxis Com New (STXS) 0.2 $2.9M NEW 564k 5.09
Essa Pharma Com New (EPIX) 0.2 $1.9M NEW 157k 11.93
Aurinia Pharmaceuticals (AUPH) 0.1 $1.7M NEW 125k 13.83
American Well Corp Cl A (AMWL) 0.1 $1.5M NEW 60k 25.33
Goodrx Hldgs Com Cl A (GDRX) 0.1 $1.4M NEW 35k 40.34
Cti Biopharma (CTIC) 0.1 $966k NEW 300k 3.22
Pieris Pharmaceuticals (PIRS) 0.1 $750k 300k 2.50

Past Filings by Rhenman & Partners Asset Management AB

SEC 13F filings are viewable for Rhenman & Partners Asset Management AB going back to 2013

View all past filings